A lymphoma driver called BCL6 suppresses the expression of cell death genes. A new molecule designed at Stanford Medicine blocks its activity and activates downstream genes to trigger cell death.
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.
In a paradigm shift, a Stanford Medicine-led study reveals a new role for a well-known protein, tau, linked to Alzheimer’s disease and other neurodegenerative disorders.